TransMedics to Report First Quarter 2025 Financial Results on May 8, 2025
TransMedics Group (Nasdaq: TMDX), a medical technology company focused on organ transplant therapy, has scheduled its first quarter 2025 financial results announcement for May 8, 2025, after market close.
The company will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on the same day. Investors can participate by dialing (844) 676-6010 (domestic) or (412) 634-6944 (international). A live and archived webcast will be available on the company's investor relations website.
TransMedics Group (Nasdaq: TMDX), un'azienda di tecnologia medica specializzata nelle terapie per il trapianto di organi, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per il 8 maggio 2025, dopo la chiusura del mercato.
La società terrà una conference call alle 16:30 ET / 13:30 PT dello stesso giorno. Gli investitori potranno partecipare chiamando il numero (844) 676-6010 (nazionale) o (412) 634-6944 (internazionale). Una trasmissione in diretta e registrata sarà disponibile sul sito web dedicato agli investitori della società.
TransMedics Group (Nasdaq: TMDX), una empresa de tecnología médica centrada en terapias para trasplantes de órganos, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 8 de mayo de 2025, después del cierre del mercado.
La compañía realizará una llamada conferencia a las 4:30 p.m. ET / 1:30 p.m. PT el mismo día. Los inversores podrán participar llamando al (844) 676-6010 (nacional) o al (412) 634-6944 (internacional). Habrá una transmisión en vivo y archivada disponible en el sitio web de relaciones con inversores de la compañía.
TransMedics Group (나스닥: TMDX)는 장기 이식 치료에 중점을 둔 의료 기술 회사로, 2025년 1분기 재무 실적 발표를 2025년 5월 8일 장 마감 후에 예정하고 있습니다.
회사는 같은 날 오후 4:30 ET / 오후 1:30 PT에 컨퍼런스 콜을 진행할 예정입니다. 투자자들은 국내 전화번호 (844) 676-6010 또는 국제 전화번호 (412) 634-6944로 참여할 수 있습니다. 회사의 투자자 관계 웹사이트에서 라이브 및 녹화된 웹캐스트를 시청할 수 있습니다.
TransMedics Group (Nasdaq : TMDX), une entreprise de technologie médicale spécialisée dans la thérapie de transplantation d'organes, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le 8 mai 2025, après la clôture du marché.
La société tiendra une conférence téléphonique à 16h30 ET / 13h30 PT le même jour. Les investisseurs pourront y participer en appelant le (844) 676-6010 (domestique) ou le (412) 634-6944 (international). Un webcast en direct et en différé sera disponible sur le site des relations investisseurs de la société.
TransMedics Group (Nasdaq: TMDX), ein Medizintechnikunternehmen mit Schwerpunkt auf Organtransplantationstherapien, hat die Veröffentlichung der Finanzergebnisse für das erste Quartal 2025 für den 8. Mai 2025 nach Börsenschluss geplant.
Das Unternehmen wird am selben Tag um 16:30 Uhr ET / 13:30 Uhr PT eine Telefonkonferenz abhalten. Investoren können teilnehmen, indem sie die Nummer (844) 676-6010 (national) oder (412) 634-6944 (international) wählen. Ein Live- und Archiv-Webcast wird auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
Investors interested in listening to the conference call may do so by dialing (844) 676-6010 for domestic callers or (412) 634-6944 for international callers and ask to be joined into the TransMedics call. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/.
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in
Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-first-quarter-2025-financial-results-on-may-8-2025-302437714.html
SOURCE TransMedics Group, Inc.
FAQ
When will TransMedics (TMDX) release Q1 2025 earnings?
How can investors join the TransMedics Q1 2025 earnings call?
Where can I find the webcast of TransMedics (TMDX) Q1 2025 earnings call?
What time is TransMedics (TMDX) Q1 2025 earnings call?
